Tumor recurrence and drug resistance properties of side population cells in high grade ovary cancer
- PMID: 25504004
- DOI: 10.1055/s-0034-1375609
Tumor recurrence and drug resistance properties of side population cells in high grade ovary cancer
Abstract
Introduction: The presence of subset of cancer stem cells (CSCs) called "Side population" (SP) cells has been identified in several solid tumors, responsible for treatment failure especially chemotherapy, and cancer relapse. The present study was aimed to isolate and characterize cancer stem like cells side population cells from high grade ovarian cancer.
Methods: The collected cancer samples were analyzed for presence of SP cells by FACS using Hoechst 33342 exclusion technique. Further the FACS sorted SP and non-SP cells were subjected to analysis of stem cell surface protein expression by western blot and immunocytochemistry, drug resistance and sphere formation assay.
Results: By FACS, we have identified 3.7% of cancer stem cell like side population cells in ovarian cancer whose prevalence was reduced to 0.5% upon treatment with verapamil an inhibitor of ABC transporter. Further, these sorted SP cells showed over expression of ABCG2 (ABC transporter), stem cell proteins such as CD144, CD44, EpCAM and antiapoptotic factor Bcl-2. Also the SP cells showed high resistance to chemotherapy drugs, have high survival rate and they are highly potential to form tumor spheres.
Conclusion: Our data suggest that ovarian cancer contain small sub-population of side population cells which shares some characteristics of stem cells. The co-expression of ABC transporters and stem cells surface markers in SP cells may associate with resistance to chemotherapeutic agents, apoptosis and also supports a role for these cells in tumor recurrence, metastasis and invasion.
© Georg Thieme Verlag KG Stuttgart · New York.
Similar articles
-
Isolation and characterization of cancer stem-like side population cells in human oral cancer cells.Oral Oncol. 2011 Sep;47(9):855-60. doi: 10.1016/j.oraloncology.2011.06.501. Epub 2011 Jul 16. Oral Oncol. 2011. PMID: 21757396
-
Abnormal Wnt signaling and overexpression of ABCG2 contributes to drug efflux properties of side population cells in nasopharyngeal carcinoma.Mol Med Rep. 2015 Sep;12(3):4352-4357. doi: 10.3892/mmr.2015.3935. Epub 2015 Jun 16. Mol Med Rep. 2015. PMID: 26081022
-
ABCG2-meditated multidrug resistance and tumor-initiating capacity of side population cells from colon cancer.Oncol Res Treat. 2014;37(11):666-8, 670-2. doi: 10.1159/000368842. Epub 2014 Oct 17. Oncol Res Treat. 2014. PMID: 25427584
-
Side population cells in human cancers.Cancer Lett. 2008 Sep 8;268(1):1-9. doi: 10.1016/j.canlet.2008.03.048. Epub 2008 May 19. Cancer Lett. 2008. PMID: 18487012 Review.
-
Technology update for the sorting and identification of breast cancer stem cells.Chin J Cancer. 2010 Mar;29(3):265-9. doi: 10.5732/cjc.009.10642. Chin J Cancer. 2010. PMID: 20193108 Review.
Cited by
-
The MEK1/2 Pathway as a Therapeutic Target in High-Grade Serous Ovarian Carcinoma.Cancers (Basel). 2021 Mar 18;13(6):1369. doi: 10.3390/cancers13061369. Cancers (Basel). 2021. PMID: 33803586 Free PMC article.
-
Characteristics of doxorubicin-selected multidrug-resistant human leukemia HL-60 cells with tolerance to arsenic trioxide and contribution of leukemia stem cells.Oncol Lett. 2018 Jan;15(1):1255-1262. doi: 10.3892/ol.2017.7353. Epub 2017 Nov 6. Oncol Lett. 2018. PMID: 29399180 Free PMC article.
-
Anti-Proliferation Effect of Theasaponin E₁ on the ALDH-Positive Ovarian Cancer Stem-Like Cells.Molecules. 2018 Jun 17;23(6):1469. doi: 10.3390/molecules23061469. Molecules. 2018. PMID: 29914196 Free PMC article.
-
New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools.J Exp Clin Cancer Res. 2019 Jun 3;38(1):234. doi: 10.1186/s13046-019-1245-5. J Exp Clin Cancer Res. 2019. PMID: 31159852 Free PMC article.
-
Drug resistance of hepatoma cells induced by ATP‑binding cassette transporter G2 by reducing intracellular drug concentration.Exp Ther Med. 2023 Feb 6;25(3):124. doi: 10.3892/etm.2023.11823. eCollection 2023 Mar. Exp Ther Med. 2023. PMID: 36845945 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous